Spartalizumab (anti-PD-1) T35396

Product Introduction
Bioactivity


英文名: Spartalizumab (anti-PD-1)

描述: Spartalizumab (anti-PD-1)是一种针对PD-1的人源IgG4抗体，抑制PD-L1和PD-L2与PD-1的结合。PDR001可与PD-1以高亲和力结合，抑制其生物活性；MW: 145.8 KD。

体内活性: In phase 1/2 studies, PDR001 has a manageable safety profile and preliminary antitumor activity in advanced solid tumors[1].

存储条件: store at -20°C

关键字: anti-PD-1 | Spartalizumab (antiPD1) | Spartalizumab | Spartalizumab (anti PD 1)

相关产品: BMS-1001 | PD-1/PD-L1-IN-10 | PDL-1 cpd 10 | BMS-1 | Tomivosertib | BMS202 hydrochloride (1675203-84-5(free base)) | Anti-Mouse PD-L1 Antibody (10F.9G2) | Durvalumab | BMS-1166-N-piperidine-CO-N-piperazine dihydrochloride | Peresolimab

Spartalizumab (anti-PD-1) T35396信息由TargetMol中国为您提供，如您想了解更多关于Spartalizumab (anti-PD-1) T35396报价、型号、参数等信息，欢迎来电或留言咨询。

注：该产品未在中华人民共和国食品药品监督管理部门申请医疗器械注册和备案，不可用于临床诊断或治疗等相关用途